Picture of Protara Therapeutics logo

TARA — Protara Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Protara Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

* Protara Therapeutics Inc  TARA.OQ  reported a quarterly
adjusted
loss of 45 cents​​ per share for the quarter ended in June,
higher than the same quarter last year, when the company
reported EPS of $-1.00.  The mean expectation of four analysts
for the quarter was for a loss of 80 cents per share. Wall
Street expected results to range from $-1.09 to -44 cents per
share.
    * Reported revenue was zero​; analysts expected zero. 
    * Protara Therapeutics Inc's reported EPS for the quarter
was a
loss of 45 cents​.
    * The company reported a quarterly loss of $9.51 million.
    * Protara Therapeutics Inc shares had fallen by 0.5% this
quarter and gained 10.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 8.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 5 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Protara
Therapeutics Inc is $26.00 
This summary was machine generated from LSEG data August 6 at
02:06 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.80          -0.45          Beat
 Mar. 31 2024      -0.92          -0.97          Missed
 Dec. 31 2023      -0.92          -0.90          Beat
 Sep. 30 2023      -0.98          -0.87          Beat

Recent news on Protara Therapeutics

See all news